Oral Semaglutide Versus Empagliflozin, Sitagliptin and Liraglutide in the UK: Long-Term Cost-Effectiveness Analyses Based on the PIONEER Clinical Trial Programme
Diabetes Therapy - United States
doi 10.1007/s13300-019-00736-6
Full Text
Open PDFAbstract
Available in full text
Date
December 12, 2019
Authors
Publisher
Springer Science and Business Media LLC